In April 2015 the FDA cleared the SpaceOAR System, the first device specifically designed for use as a prostate-rectum hydrogel spacer for prostate cancer patients undergoing radiotherapy. Click here for the Instructions for Use.

SpaceOAR System is a novel technology and health insurance providers may require additional information to help them understand the procedure and technology. Augmenix offers assistance to health care providers in their efforts to educate payers and navigate the reimbursement process.

For questions regarding SpaceOAR:

  • General Reimbursement Information
  • Prior Authorization Assistance
  • Claims Appeal Assistance

Contact us:

We Can Help You Navigate Through the Reimbursement Process

Check out Our Provider Support Resources

Disclaimer: It is always the provider’s responsibility to determine and report the appropriate procedure and supply codes based upon medical necessity and procedures and supplies provided to the patient. Coding and reimbursement information is provided for educational purposes and does not assure coverage of the specific item or service in a given case. Contact your local Medicare Administrator Contractor (MAC) or CMS for specific information as payment rates listed are subject to change. To the extent that you submit cost information to Medicare, Medicaid or any other reimbursement program to support claims for services or items, you are obligated to accurately report the actual price paid for such items, including any subsequent adjustments. CPT® five-digit numeric codes, descriptions, and numeric modifiers only are Copyright AMA. All rights reserved.